OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
OPKO Health (Nasdaq: OPK) said its management team will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, held January 12-15, 2026. Management will host one-on-one investor meetings and take part in a fireside chat on Wednesday, January 14, 2026 at 1:30 p.m. PT. The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health's website.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
OPK was up 0.79%, while key diagnostics/biotech peers like NEOG (+3.71%), NEO (+2.81%), GRAL (+7.51%), CDNA (+3.02%) and TWST (+5.18%) also showed gains, but no peers appeared in the momentum scanner and no same-day peer headlines were recorded, suggesting this conference item was stock-specific rather than a sector-driven catalyst.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 19 | Conference participation | Neutral | -0.8% | Piper Sandler healthcare conference attendance and investor meetings announcement. |
| Oct 29 | Earnings results | Neutral | +2.1% | Q3 2025 results with profit supported by oncology asset sale to Labcorp. |
| Oct 29 | Strategic partnership | Positive | -0.7% | ModeX collaboration with Regeneron using MSTAR platform and milestone economics. |
| Oct 28 | Clinical trial start | Positive | -0.7% | First patient dosed in Phase 1/2a trial of MDX2004 for advanced cancers. |
| Oct 22 | Earnings call notice | Neutral | +0.7% | Scheduling notice for Q3 2025 financial results release and conference call. |
Recent conference participation headlines have had modest price impact, while major strategic news (collaborations, trials, earnings) has sometimes seen price moves that diverge from the apparent positivity of the announcements.
Over the last few months, OPKO reported Q3 2025 results on October 29, 2025, highlighting $151.7M in revenue, positive operating income of $48.1M, and a significant asset sale to Labcorp. Around the same time, its ModeX unit began a Phase 1/2a trial for MDX2004 and entered a multispecific antibody collaboration with Regeneron valued at potentially over $1 billion. The company has also issued multiple conference participation notices, including Piper Sandler’s 37th Annual Healthcare Conference, similar in nature to today’s J.P. Morgan appearance update.
Market Pulse Summary
This announcement highlights OPKO’s participation at the 44th Annual J.P. Morgan Healthcare Conference, including a fireside chat on January 14, 2026. In the months leading up to this, OPKO reported Q3 2025 revenue of $151.7M, net income of $21.6M, and cash of $415.2M, alongside a $192.5M oncology asset sale and a collaboration with Regeneron. Investors may monitor upcoming conference commentary for updates on pipeline progress, partnership execution, and how the company addresses the disclosed $246M foreign tax assessment.
AI-generated analysis. Not financial advice.
MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14th at 1:30 p.m. Pacific time.
The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
When will OPKO Health (OPK) present at the 2026 J.P. Morgan Healthcare Conference?
How can investors watch OPKO Health's (OPK) fireside chat from J.P. Morgan 2026?
Will OPKO Health (OPK) hold investor meetings at the J.P. Morgan conference?
What time is OPKO Health's (OPK) fireside chat on January 14, 2026?
Where is the 44th Annual J.P. Morgan Healthcare Conference being held in 2026?
Where can I find the replay of OPKO Health's (OPK) presentation after the conference?
